Printer Friendly

BIOGEN APPOINTS DANIEL A. CUOCO VICE PRESIDENT AND GENERAL COUNSEL

 BIOGEN APPOINTS DANIEL A. CUOCO VICE PRESIDENT AND GENERAL COUNSEL
 CAMBRIDGE, Mass. March 19 /PRNewswire/ -- Biogen, Inc. (NASDAQ: BGEN) announced today the appointment of Daniel A. Cuoco as vice president and general counsel. He will assume responsibilty for Biogen's legal affairs on April 1.
 Cuoco is the former senior vice president, general counsel and secretary of Squibb Corporation. He was associated with Squibb and its successor corporation, Bristol-Meyers Squibb Company, from 1971-1990 and served on Squibb's board of directors from 1984-1989. He joins Biogen from Sills Cummis, a law firm in Newark, N.J., where he is a partner specializing in corporate law. He began his legal career at the New York law firm of Dewey Ballantine.
 James L. Vincent, Biogen chairman and chief executive officer, commented, "Dan has more than 20 years experience in both law and senior corporate management and brings an extraordinary breadth of knowledge about all aspects of law relating to the pharmaceutical industry. As Biogen moves to become an operating company, we recognize the necessity to broaden the experience base of our legal operations. We are delighted that a person of Dan's caliber is joining us to provide leadership in this key position."
 Cuoco received a B.A. from Iona college and a J.D. from Columbia University School of Law. He and his wife Joanne will be relocating to Boston from Princeton, N.J.
 Biogen, Inc., headquartered in Cambridge, is a biopharmaceutical company principally engaged in developing and manufacturing drugs for human health care through genetic engineering. The company's revenues are generated from the worldwide sales by licensees of five products including alpha interferon, hepatitis vaccines and hepatitis diagnostic products. Biogen is focused primarily on developing and testing products used for the treatment of cardiovascular disease, inflammatory diseases, AIDS and certain cancers.
 -0- 3/19/92
 /CONTACT: Kathryn R. Bloom of Biogen, 617-252-9851/
 (BGEN) CO: Biogen, Inc. ST: Massachusetts IN: MTC SU: PER


TM-EG -- NE006 -- 9633 03/19/92 11:28 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 19, 1992
Words:328
Previous Article:GREENWICH HARBOR INN WILL SPRING INTO ACTION AT NOON ON FRIDAY, MARCH 20, THE FIRST DAY OF SPRING
Next Article:FORD REPORTS 1991 KANSAS CITY EMPLOYMENT, PRODUCTION, SALES AND CONTRIBUTIONS
Topics:


Related Articles
BIOGEN APPOINTS LAWRENCE S. DANIELS VICE PRESIDENT-MARKETING AND BUSINESS DEVELOPMENT
BIOGEN ANNOUNCES RESIGNATION OF DANIEL A. CUOCO, VICE PRESIDENT AND GENERAL COUNSEL
BIOGEN APPOINTS THOMAS J. BUCKNUM AS CHIEF CORPORATE COUNSEL AND ASSOCIATE GENERAL COUNSEL

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters